Hereditary Angioedema: Implications of Management

Mohini Pathria, Guha Krishnaswamy, Juan C. Guarderas

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Hereditary angioedema (HAE) is a genetic condition that is characterized by frequent episodes of localized angioedema. It is a rare disorder that a primary care provider, otolaryngologist, dermatologist, or rheumatologist may encounter only occasionally. This disease is being reviewed because of the significant advances in further understanding the genetics, biology, and therapeutic management surrounding the condition. Histamine-mediated angioedema responds to steroids, antihistamines, and epinephrine, whereas bradykinin-mediated angioedema is resistant to those interventions and requires specialized therapy. Previously used medications have significant adverse effects. Approved medications for HAE have been effective in decreasing morbidity and mortality in patients with this condition. We review the presentation, diagnosis, and available pharmaceutical options for HAE and explore the limitations of implementing recommended therapy.

Original languageEnglish (US)
Pages (from-to)101-106
Number of pages6
JournalSouthern medical journal
Issue number2
StatePublished - Feb 1 2017


  • C1 esterase inhibitor
  • C1 esterase inhibitor deficiency
  • C1 inhibitor deficiency
  • hereditary angioedema

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Hereditary Angioedema: Implications of Management'. Together they form a unique fingerprint.

Cite this